Atlas FDA

OCD MT Cap (85-00397-000)

FDA 510(k) clearance K231350 · decided 2023-06-08

Clearance details

K-number
K231350
Device name
OCD MT Cap (85-00397-000)
Applicant
Neuronetics
Decision
Substantially Equivalent
Date received
2023-05-09
Decision date
2023-06-08
Days to decision
30 days
Clearance type
Special
Product code
QCI
Device class
2
Regulation number
882.5802
Medical specialty
Neurology
Advisory committee
Neurology
Location
Malvern, PA, US
Third-party review
No
Expedited review
No

+ Add to Predicate Builder ◉ Watch Neuronetics

Need this as data, not a web page?

Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.

Similar devices under this product code

Devices cleared under the same product code - the starting set for predicate research.

RecordFirmDate
Ultimate rTMS for OCD (M-series) (K243459)Brain Ultimate, Inc.2025-04-17
BTL-99-OC (K230657)BTL Industries, Inc.2024-02-01
CloudTMS Edge for OCD (K233742)Teleemg, LLC2023-12-22
CloudTMS for OCD (K221129)Teleemg, LLC2023-03-10
NeuroStar Advanced Therapy for adjunctive treatment of OCD, NeuroStar Advanced Therapy System, NeuroStar TMS Therapy System, NeuroStar Advanced Therapy for Mental Health, NeuroStar (K212289)Neuronetics, Inc.2022-05-06
MagVenture TMS Therapy – for treatment of OCD, MagVenture TMS Therapy system (K193006)Tonica Elektronik A/S2020-08-09
Brainsway Deep TMS System (K183303)Brainsway , Ltd.2019-03-08
Brainsway Deep Transcranial Magnetic Stimulation (DTMS) System (DEN170078)Brainways , Ltd.2018-08-17

Recalls involving this device

No recalls on record reference this clearance.